rs2295079
From SNPedia
| is a | snp |
| is | mentioned by |
| dbSNP | rs2295079 |
| dbSNP (classic) | rs2295079 |
| ClinGen | rs2295079 |
| ebi | rs2295079 |
| HLI | rs2295079 |
| Exac | rs2295079 |
| Gnomad | rs2295079 |
| Varsome | rs2295079 |
| LitVar | rs2295079 |
| Map | rs2295079 |
| PheGenI | rs2295079 |
| Biobank | rs2295079 |
| 1000 genomes | rs2295079 |
| hgdp | rs2295079 |
| ensembl | rs2295079 |
| geneview | rs2295079 |
| scholar | rs2295079 |
| rs2295079 | |
| pharmgkb | rs2295079 |
| gwascentral | rs2295079 |
| openSNP | rs2295079 |
| 23andMe | rs2295079 |
| SNPshot | rs2295079 |
| SNPdbe | rs2295079 |
| MSV3d | rs2295079 |
| GWAS Ctlg | rs2295079 |
| Max Magnitude | 0 |
[PMID 31303410] SNPs Within the MTOR Gene Are Associated With an Increased Risk of Developing De Novo Diabetes Mellitus Following the Administration of Everolimus in Liver Transplant Recipients.
[PMID 31467112] Breast cancer risk-associated SNPs in the mTOR promoter form de novo KLF5 and ZEB1 binding sites that influence the cellular response to paclitaxel.
